{"method": [["TABLE 1. Demographic, clinical, and neuropsychological variables                   Controls PD PDD 2 /F                                                     Parameter                 (n 16)                 (n 16)                 (n 16)                 statistic                 P                                                                     Age (yr)                 71.31 7.5                 72.87 4.4                 70.06 7.9                 1.46                 0.482                                             Gender (men/women)                 5/11                 6/10                 5/11                 0.19                 0.91                                             Education (yr)                 10.19 5.2                 9.01 5.2                 6.62 4.5                 2.09                 0.135                                             Hamilton depression                 0.69 1.2                 1.67 2.1                 2.94 4.6                 3.44                 0.179                                             Disease evolution (yr)                 \u2014                 11.25 6.8                 13.33 5.3                 2.59                 0.108                                             Hoehn and Yahr                 \u2014                 2.69 0.68                 3.37 1.1                 4.11                 0.042 a                                             UPDRS III                 \u2014                 25.64 13.5                 36.00 13.2                 4.19                 0.051                                             MMSE                 29.37 1.1                 28.62 1.0                 17.33 5.5                 33.52                 0.0005 a,b,c                                             RAVLT learning                 36.69 6.0                 34.87 6.46                 15.14 7.96                 45.08                 0.0005 a,c                                             RAVLT forgetting                 3.05 3.97                 7.93 6.19                 15.11 12.2                 12.59                 0.002 a,b,c                                             a Differences between PD                 and PDD.                                                                                                             b Differences between                 controls and PD.                                                                                                             c Differences between controls                 and PDD.                                                                                                             PD, Parkinson\u2019s disease;                 PDD, Parkinson\u2019s disease                 with dementia; UPDRS,                 Unified Parkinson\u2019s Disease                 Rating Scale; MMSE,                 Mini-Mental                                             Examination; RAVLT, Rey                 Auditory-Verbal Learning                 Test.                                                                                                    Controls PD PDD 2 /F Parameter (n 16) (n 16) (n 16) statistic P Age (yr) 71.31 7.5 72.87 4.4 70.06 7.9 1.46 0.482 Gender (men/women) 5/11 6/10 5/11 0.19 0.91 Education (yr) 10.19 5.2 9.01 5.2 6.62 4.5 2.09 0.135 Hamilton depression 0.69 1.2 1.67 2.1 2.94 4.6 3.44 0.179 Disease evolution (yr) \u2014 11.25 6.8 13.33 5.3 2.59 0.108 Hoehn and Yahr \u2014 2.69 0.68 3.37 1.1 4.11 0.042 a UPDRS III \u2014 25.64 13.5 36.00 13.2 4.19 0.051 MMSE 29.37 1.1 28.62 1.0 17.33 5.5 33.52 0.0005 a,b,c RAVLT learning 36.69 6.0 34.87 6.46 15.14 7.96 45.08 0.0005 a,c RAVLT forgetting 3.05 3.97 7.93 6.19 15.11 12.2 12.59 0.002 a,b,c a Differences between PD and PDD. b Differences between controls and PD. c Differences between controls and PDD. PD, Parkinson\u2019s disease; PDD, Parkinson\u2019s disease with dementia; UPDRS, Unified Parkinson\u2019s Disease Rating Scale; MMSE, Mini-Mental State Examination; RAVLT, Rey Auditory-Verbal Learning Test.", {"pattern": {"nes": {"Unified": 2, "Hamilton": 2, "PD": 1, "MMSE": 2, "III": 1, "UPDRS": 2, "RAVLT": 4, "Disease Rating Scale": 1, "Rey": 2, "Yahr": 2, "Controls": 1, "Hoehn": 1, "Test": 1, "TABLE": 1, "PDD": 6, "Scale": 1, "Controls PD": 2, "UPDRS III": 2}, "cds": {"evolution": 2, "MMSE": 2, "Gender": 2, "\u2014": 2, "Education": 2, "Parameter": 2, "depression": 2}}, "sp": 0, "ne": 135, "cd": 0, "sid": "29", "total": 135, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["REFERENCES                  1. Braak H, Braak E. Pathoanatomy of Parkinson\u2019s disease. J Neurol 2000;247(Suppl.):II/3\u2013II/10.          2. de la Monte SM, Wells SE, Hedley-Whyte ET, Growdon JH. Neuropathological distinction between Parkinson\u2019s dementia and Parkinson\u2019s plus Alzheimer\u2019s disease. Ann Neurol 1989;26:309 \u2013 320.          3. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JGL. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000;47:718 \u2013728.          4. Churchyard A, Lees AJ. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson\u2019s disease. Neurology 1997;49:1570 \u20131576.          5. Harding AJ, Stimson E, Henderson JM, Halliday GM. Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 2002;125:2431\u20132445.          6. Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer\u2019s disease, Parkinson\u2019s disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996; 46:678 \u2013 681.          7. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson\u2019s disease is associated with hippocampal atrophy. Mov Disord 2003;18:784 \u2013790.          8. Summerfield C, G  \u0301mez-Ans  \u0301n B, Tolosa E, et al. Dementia in Parkinson disease. A proton magnetic resonance spectroscopy study. Arch Neurol 2002;59:1415\u20131420.          9. Summerfield C, Junqu  \u0301 C, Tolosa E, et al. Structural brain changes in Parkinson\u2019s disease with dementia: a voxel-based morphometry study. Arch Neurol 2005;62:281\u2013285.          10. Daniel SE, Lees AJ. Parkinson\u2019s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993;39: 165\u2013172.          11. Folstein MF, Folstein SE, McHugh PR. \u201cMini-Mental state.\u201d A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189 \u2013198.          12. Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995.          13. Aylward EH, Li Q, Honeycutt NA, et al. MRI volumes of the hippocampus and amygdala in adults with Down\u2019s syndrome with and without dementia. Am J Psychiatry 1999;156:564 \u2013568.          14. Fahn S, Elton RL, UPDRS Program Members. Unified Parkinson\u2019s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson\u2019s disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987. p 153\u2013163.          15. Jankovic J, McDermott M, Carter J. Variable expression of Parkinson\u2019s disease: A baseline analysis of the DATATOP cohort. Neurology 1990;40:1529 \u20131534.          16. Mattila PM, R  \u0308ytt  \u0308 M, Torikka H, Dickson DW, Rinne JO. Cor- tical Lewy bodies and Alzheimer-type changes in patients with Parkinson\u2019s disease. Acta Neuropathol 1998;95:576 \u2013582.          17. Mattila PM, Rinne JO, Helenius H, R  \u0308ytt  \u0308 M. Neuritic degeneration in the hippocampus and amygdala in Parkinson\u2019s disease in relation to Alzheimer pathology. Acta Neuropathol 1999;98:157\u2013 164.          18. Del Tredicci K, R  \u0308b U, de Vos RAI, Bohl JRE, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropath Exp Neurol 2002;61:413\u2013 426.          19. Braak H, Braak E, Yilmazer D, et al. Amygdala pathology in Parkinson\u2019s disease. Acta Neuropathol (Berl) 1994;88:493\u2013500.          20. Yang TT, Menon V, Eliez S, et al. Amygdalar activation associated with positive and negative facial expressions. Neuroreport 2002; 13:1737\u20131741.          21. Jacobs DH, Shuren J, Bowers D, Heilman KM. Emotional facial imagery, perception, and expression in Parkinson\u2019s disease. Neurology 1995;45:1696 \u20131702.          22. Crucian GP, Huang L, Barret AM, et al. Emotional conversations in Parkinson\u2019s disease. Neurology 2001;56:159 \u2013165.          23. Tessitore A, Hariri AR, Fera F, et al. Dopamine modulates the response of the human amygdala: a study in Parkinson\u2019s disease. J Neurosci 2002;22:9099 \u20139103.          24. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology. Later-developing dementia and loss of the levodopa response. Arch Neurol 2002;59:102\u2013112.          25. Kim H, Gearing M, Mirra S. Ubiquin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 1995; 45:1768 \u20131770.          26. Good CD, Scahill RI, Fox NC, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002;17:29 \u2013 46.                Movement Disorders, Vol. 20, No. 5, 2005", {"pattern": {"nes": {"Henderson JM": 1, "Hely MA": 1, "Bowers D": 1, "Yilmazer D": 1, "Corbridge E": 1, "Braak E": 1, "Glassberg K": 1, "Braak H": 2, "Marsden CD": 1, "McDermott M": 1, "H123ycutt NA": 1, "Laakso MP": 1, "Fox NC": 1, "Growdon JH": 1, "Camicioli R": 1, "Torikka H": 1, "McHugh PR": 1, "MRI": 1, "Macmillan Healthcare Information": 1, "Disease Rating Scale": 1, "Automatic": 1, "Jankovic J": 1, "Fera F": 1, "Daniel SE": 1, "Goldstein M": 1, "Disease Society Brain Bank": 1, "London": 1, "Dopamine": 1, "Rinne JO": 2, "Jacobs DH": 1, "Tolosa E": 2, "Eliez S": 1, "Dickson DW": 2, "Gearing M": 1, "Helenius H": 1, "Yang TT": 1, "Boeve BF": 1, "Alzheimer": 1, "Berl": 1, "Florham Park": 1, "Amygdala": 1, "Junqu": 1, "Mattila PM": 2, "DATATOP": 1, "Bohl JRE": 1, "Mirra": 1, "UPDRS": 1, "Harding AJ": 1, "ET": 1, "Lezak MD": 1, "MD": 1, "Calne DB": 1, "Parkinson": 3, "Folstein SE": 1, "Shuren J": 1, "Hariri AR": 1, "NC": 1, "Crucian GP": 1, "Li Q": 1, "Barret AM": 1, "Society Brain Bank": 1, "Wells SE": 1, "Huang L": 1, "Lewy": 1, "Moore MM": 1, "Oxford University Press": 1, "Ann Neurol": 2, "Vol": 1, "Kim H": 1, "Menon V": 1, "New York": 1, "Partanen K": 1, "Riekkinen P": 1, "Elton RL": 1, "DB": 1, "Ahlskog JE": 1, "Fahn S": 1, "Morris JGL": 1, "Clinical": 1, "Brain Bank": 1, "UPDRS Program Members": 1, "Scahill RI": 1, "Folstein MF": 1, "Stimson E": 1, "Parisi JE": 1, "Lees AJ": 2, "Kaye JA": 1, "Aylward EH": 1, "Hippocampal": 1, "AR": 1, "Heilman KM": 1, "Folstein": 1, "Apaydin H": 1, "Unified": 1, "Kinney A": 1, "Carter": 1, "Braak": 2, "Brain": 1, "Cordato NJ": 1, "Dementia": 1}, "cds": {"\u20131702": 1, "\u2013582": 1, "\u20131576": 1, "\u20131770": 1, "\u2013568": 1, "\u2013790": 1, "\u20131534": 1, "p": 1, "\u2013728": 1, "\u20139103": 1, "\u2013165": 1, "\u2013198": 1}}, "sp": 0, "ne": 108, "cd": 0, "sid": "112", "total": 108, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}]], "findings": [["A post-hoc test demonstrated that the differences were due to PDD and control group comparisons for the amygdala", {"pattern": {"sp_index": 446, "confidence": 1.0, "sub": ["test"], "pred": ["demonstrated"], "cds": {}, "nes": {"PDD": 1}}, "sp": 0, "ne": 3, "cd": 0, "sid": "6", "total": 3, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["In nondemented PD subjects, we observed an 11% reduction in the amygdala and a 10% reduction in the hippocampus compared with that in controls.", {"pattern": {"sp_index": 68, "confidence": 2, "sub": ["we"], "pred": ["observed"], "cds": {"reduction": 2}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "18", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["In summary, demented PD patients have clear amygdalar and hippocampal atrophy that remains statistically significant after controlling for global cerebral atrophy.", {"pattern": {"sp_index": 66, "confidence": 1.0, "sub": ["PD", "patients"], "pred": ["have"], "cds": {}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "19", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["4 PD patients without dementia exhibit similar pathological changes in the hippocampus and the amygdala, including atrophy and Lewy body formation.", {"pattern": {"sp_index": 59, "confidence": 1.0, "sub": ["PD", "patients"], "pred": ["exhibit"], "cds": {"patients": 1}, "nes": {"Lewy": 1, "PD": 1}}, "sp": 0, "ne": 15, "cd": 126, "sid": "23", "total": 141, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Reductions in hippocampal volume are observed in PD patients with and without dementia.", {"pattern": {"sp_index": 215, "confidence": 1.0, "sub": ["Reductions"], "pred": ["are", "observed"], "cds": {}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "26", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["The patient sample comprised 16 subjects with an initial diagnosis of idiopathic PD who in later years met criteria for dementia and 16 PD patients who did not.", {"pattern": {"sp_index": 775, "confidence": 2, "sub": ["patient", "sample"], "pred": ["comprised"], "cds": {"patients": 1, "subjects": 1}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 152, "sid": "31", "total": 164, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Patients were recruited from an outpatient movement disorders clinic (PD and Movement Disorders Unit, Department of Neurology, Hospital Clinic, Barcelona).", {"pattern": {"sp_index": 39, "confidence": 1.0, "sub": ["Patients"], "pred": ["were", "recruited"], "cds": {}, "nes": {"Movement Disorders Unit": 1, "Barcelona": 1, "Hospital Clinic": 1, "Patients": 1, "Neurology": 1, "PD": 1}}, "sp": 0, "ne": 13, "cd": 0, "sid": "32", "total": 13, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["15 Neuropsychological testing showed significant differences between the groups in MMSE and RAVLT scores (see Table 1).", {"pattern": {"sp_index": 629, "confidence": 0.5, "sub": ["Neuropsychological", "testing"], "pred": ["showed"], "cds": {"testing": 1}, "nes": {"Table": 1, "RAVLT": 1, "MMSE": 1}}, "sp": 0, "ne": 42, "cd": 0, "sid": "70", "total": 42, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Regarding the morphometric analysis, the PD group showed decreased volume in both structures (amygdala, 11%; hippocampus, 10%), although the reductions did not reach statistical significance.", {"pattern": {"sp_index": 402, "confidence": 1.0, "sub": ["PD", "group"], "pred": ["showed"], "cds": {"%": 2}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "71", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Post-hoc analysis revealed significant differences in corrected amygdala (P 0.008) and corrected hippocampus (P 0.004) between the PDD and control group.", {"pattern": {"sp_index": 12, "confidence": 1.0, "sub": ["Post-hoc", "analysis"], "pred": ["revealed"], "cds": {}, "nes": {"PDD": 1}}, "sp": 0, "ne": 3, "cd": 0, "sid": "74", "total": 3, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Memory also showed significant correlations with both structures.", {"pattern": {"sp_index": 522, "confidence": 0.5, "sub": ["Memory"], "pred": ["showed"], "cds": {}, "nes": {"Memory": 1}}, "sp": 0, "ne": 4, "cd": 0, "sid": "77", "total": 4, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["In demented patients we found a significant correlation between RAVLT delayed recall and hippocampal volume.", {"pattern": {"sp_index": 14, "confidence": 2, "sub": ["we"], "pred": ["found"], "cds": {}, "nes": {"RAVLT": 1}}, "sp": 0, "ne": 5, "cd": 0, "sid": "79", "total": 5, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["In agreement with previous postmortem volumetric studies, 2,3 our results showed significant reductions in the amygdala and hippocampus in PD patients with dementia.", {"pattern": {"sp_index": 90, "confidence": 1.0, "sub": ["our", "results"], "pred": ["showed"], "cds": {}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "82", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["5 Three-dimensional volumetric postmortem studies of regional brain atrophy in demented PD have reported amygdalar reductions of 18% 2 and 29% 3 compared with that in age-matched normal controls.", {"pattern": {"sp_index": 1113, "confidence": 1.0, "sub": ["postmortem", "studies"], "pred": ["have", "reported"], "cds": {"%": 2, "studies": 1}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "86", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Our results in PDD patients were similar (a 21% reduction).", {"pattern": {"sp_index": 170, "confidence": 1.0, "sub": ["Our", "results"], "pred": ["were"], "cds": {"reduction": 1}, "nes": {"PDD": 1}}, "sp": 0, "ne": 3, "cd": 0, "sid": "87", "total": 3, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["In a well-selected sample of nondemented, levodopa- responsive PD, a neuropathological study revealed a 20% global amygdalar volume reduction compared with that in controls.", {"pattern": {"sp_index": 444, "confidence": 1.0, "sub": ["study"], "pred": ["revealed"], "cds": {"reduction": 1}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "89", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Hippocampal volumetric atrophy in PD has been reported on previously using MRI 6,7 and in postmortem studies.", {"pattern": {"sp_index": 622, "confidence": 0.5, "sub": ["atrophy"], "pred": ["has", "been", "reported"], "cds": {}, "nes": {"MRI": 1, "PD": 1, "Hippocampal": 1}}, "sp": 0, "ne": 38, "cd": 0, "sid": "97", "total": 38, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["2,3 Histopathological studies have described Lewy bodies and Alzheimer\u2019s- type changes in the hippocampus in demented PD patients, both of which probably contribute to cognitive loss.", {"pattern": {"sp_index": 1113, "confidence": 1.0, "sub": ["Histopathological", "studies"], "pred": ["have", "described"], "cds": {"studies": 1}, "nes": {"Lewy": 1, "PD": 1}}, "sp": 0, "ne": 15, "cd": 0, "sid": "98", "total": 15, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["4,17 Demented PD patients have increased neurofibrillary tangles in the CA1 sector of the hippocampus.", {"pattern": {"sp_index": 1370, "confidence": 1.0, "sub": ["Demented", "PD", "patients"], "pred": ["have", "increased"], "cds": {"patients": 1}, "nes": {"CA1": 1, "PD": 1}}, "sp": 0, "ne": 26, "cd": 126, "sid": "100", "total": 152, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["In a previous study using voxel-based morphometry (VBM) in the same sample of demented patients, 9 we also observed hippocampal atrophy in PDD compared with that in controls, but we did not obtain significant results for the amygdala.", {"pattern": {"sp_index": 68, "confidence": 2, "sub": ["we"], "pred": ["observed"], "cds": {}, "nes": {"PDD": 1, "VBM": 1}}, "sp": 0, "ne": 20, "cd": 0, "sid": "104", "total": 20, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["In summary, we found amygdalar and hippocampal volume reductions in PD patients with dementia.", {"pattern": {"sp_index": 14, "confidence": 2, "sub": ["we"], "pred": ["found"], "cds": {}, "nes": {"PD": 1}}, "sp": 0, "ne": 12, "cd": 0, "sid": "108", "total": 12, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}]], "goal": [["We carried out magnetic resonance imaging (MRI) volumetric studies in 16 patients with PD and dementia (PDD), 16 patients with PD without dementia (PD), and 16 healthy subjects.", {"pattern": {"sp_index": 71, "confidence": 1, "sub": ["We"], "pred": ["carried"], "cds": {"patients": 2, "subjects": 1}, "nes": {"PDD": 1, "MRI": 1, "PD": 1}}, "sp": 0, "ne": 38, "cd": 152, "sid": "4", "total": 190, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}], ["Because PDD patients had longer disease duration than PD patients did (by around 2 years), we carried out correlations of this variable with volumetric MRI data.", {"pattern": {"sp_index": 301, "confidence": 1, "sub": ["we"], "pred": ["carried"], "cds": {"years": 1}, "nes": {"PDD": 1, "MRI": 1, "PD": 1}}, "sp": 0, "ne": 38, "cd": 6, "sid": "80", "total": 44, "doc_id": "./20-test-papers/15645532_annotated_ann.json"}]]}